Literature DB >> 29298455

Preterm Preeclampsia with Severe Features: Composite Maternal and Neonatal Morbidities Associated with Fetal Growth Restriction.

Olaide Ashimi Balogun1, Raminder K Khanagura1, Heather R Kregel1, Farah H Amro1, Baha M Sibai1, Suneet P Chauhan1.   

Abstract

OBJECTIVE: The objective of this study was to compare adverse pregnancy outcomes between fetuses with estimated fetal weight (EFW) < 10 to > 10% in women with preterm preeclampsia (PE) with severe features.
MATERIALS AND METHODS: All women with preterm PE with severe features and nonanomalous singletons with EFW were identified at a tertiary center. Women with oligohydramnios or absent/reversed umbilical Doppler velocimetry were excluded. Using multivariable analysis, we compared the composite maternal and neonatal morbidities (CMM and CNM) between those with appropriate for gestational age (AGA) fetal growth, defined as EFW at 10 to 90th versus those with fetal growth restriction (FGR), defined as EFW < 10th percentile for gestational age (GA).
RESULTS: In this study, 165 patients were included; 112 had EFW at 10th to 90th percentile, and 53 had FGR. Of the 53 with FGR, 33 (62%) had EFW at 5 to 9% for GA and 20 (38%) had EFW < fifth percentile for GA. The CMM was significantly higher among women with FGR versus AGA (29 vs. 7%; p < 0.001). The CNM was significantly higher with FGR versus AGA (20 vs. 6%; p = 0.01).
CONCLUSION: Women with preterm PE with severe features and FGR, when compared with those with AGA, have significantly higher risk of CMM and CNM. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29298455     DOI: 10.1055/s-0037-1617456

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  4 in total

1.  Abnormal expression and clinical significance of 25-hydroxyvitamin D and sFlt-1 in patients with preeclampsia.

Authors:  Xinhua Chen; Xuxia Xi; Fan Cui; Ming Wen; Aijuan Hong; Zemei Hu; Juan Ni
Journal:  J Int Med Res       Date:  2019-09-12       Impact factor: 1.671

2.  Semiautonomous Treatment Algorithm for the Management of Severe Hypertension in Pregnancy.

Authors:  Courtney Martin; James Pappas; Kim Johns; Heather Figueroa; Kevin Balli; Ruofan Yao
Journal:  Obstet Gynecol       Date:  2021-02-01       Impact factor: 7.661

3.  Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study.

Authors:  Masaya Takahashi; Shintaro Makino; Kyoko Oguma; Haruka Imai; Ai Takamizu; Akari Koizumi; Koyo Yoshida
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-06       Impact factor: 3.007

4.  Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study.

Authors:  Benjamin S Umezuluike; Chidebe C Anikwe; Oluomachi C Nnachi; Bobbie C A Iwe; Chinedu C Ifemelumma; Ikechukwu B O Dimejesi
Journal:  Heliyon       Date:  2021-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.